E. D. Özyılmaz And T. ÇOMOĞLU, "Development of pediatric orally disintegrating mini-tablets containing atomoxetine hydrochloride-β-cyclodextrin inclusion complex using experimental design," Drug Development and Industrial Pharmacy , vol.48, no.11, pp.667-681, 2022
Özyılmaz, E. D. And ÇOMOĞLU, T. 2022. Development of pediatric orally disintegrating mini-tablets containing atomoxetine hydrochloride-β-cyclodextrin inclusion complex using experimental design. Drug Development and Industrial Pharmacy , vol.48, no.11 , 667-681.
Özyılmaz, E. D., & ÇOMOĞLU, T., (2022). Development of pediatric orally disintegrating mini-tablets containing atomoxetine hydrochloride-β-cyclodextrin inclusion complex using experimental design. Drug Development and Industrial Pharmacy , vol.48, no.11, 667-681.
Özyılmaz, Emine, And TANSEL ÇOMOĞLU. "Development of pediatric orally disintegrating mini-tablets containing atomoxetine hydrochloride-β-cyclodextrin inclusion complex using experimental design," Drug Development and Industrial Pharmacy , vol.48, no.11, 667-681, 2022
Özyılmaz, Emine D. And ÇOMOĞLU, TANSEL. "Development of pediatric orally disintegrating mini-tablets containing atomoxetine hydrochloride-β-cyclodextrin inclusion complex using experimental design." Drug Development and Industrial Pharmacy , vol.48, no.11, pp.667-681, 2022
Özyılmaz, E. D. And ÇOMOĞLU, T. (2022) . "Development of pediatric orally disintegrating mini-tablets containing atomoxetine hydrochloride-β-cyclodextrin inclusion complex using experimental design." Drug Development and Industrial Pharmacy , vol.48, no.11, pp.667-681.
@article{article, author={Emine Dilek Özyılmaz And author={TANSEL ÇOMOĞLU}, title={Development of pediatric orally disintegrating mini-tablets containing atomoxetine hydrochloride-β-cyclodextrin inclusion complex using experimental design}, journal={Drug Development and Industrial Pharmacy}, year=2022, pages={667-681} }